RU2012123184A - METHOD FOR CONTROLLED REDUCTION OF THE AGGREGATION ACTIVITY OF THROMBOCYTES BY MEXIDOL IN THE EXPERIMENT - Google Patents

METHOD FOR CONTROLLED REDUCTION OF THE AGGREGATION ACTIVITY OF THROMBOCYTES BY MEXIDOL IN THE EXPERIMENT Download PDF

Info

Publication number
RU2012123184A
RU2012123184A RU2012123184/14A RU2012123184A RU2012123184A RU 2012123184 A RU2012123184 A RU 2012123184A RU 2012123184/14 A RU2012123184/14 A RU 2012123184/14A RU 2012123184 A RU2012123184 A RU 2012123184A RU 2012123184 A RU2012123184 A RU 2012123184A
Authority
RU
Russia
Prior art keywords
mexidol
experiment
thrombocytes
controlled reduction
aggregation activity
Prior art date
Application number
RU2012123184/14A
Other languages
Russian (ru)
Other versions
RU2512788C2 (en
Inventor
Олеся Викторовна Щекочихина
Алексей Александрович Браш
Наталья Геннадьевна Браш
Original Assignee
Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Амурская Государственная Медицинская Академия" Министерства Здравоохранения Российской Федерации
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Амурская Государственная Медицинская Академия" Министерства Здравоохранения Российской Федерации filed Critical Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Амурская Государственная Медицинская Академия" Министерства Здравоохранения Российской Федерации
Priority to RU2012123184/14A priority Critical patent/RU2512788C2/en
Publication of RU2012123184A publication Critical patent/RU2012123184A/en
Application granted granted Critical
Publication of RU2512788C2 publication Critical patent/RU2512788C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Способ управляемого снижения агрегационной активности тромбоцитов в эксперименте, включающий использование лекарственных препаратов, отличающийся тем, что в качестве лекарственного препарата используют мексидол в дозе от 0.100 до 0.800 мг/мл.A method of controlled reduction of platelet aggregation activity in an experiment, including the use of drugs, characterized in that mexidol is used as a drug in a dose of 0.100 to 0.800 mg / ml.

Claims (1)

Способ управляемого снижения агрегационной активности тромбоцитов в эксперименте, включающий использование лекарственных препаратов, отличающийся тем, что в качестве лекарственного препарата используют мексидол в дозе от 0.100 до 0.800 мг/мл. A method of controlled reduction of platelet aggregation activity in an experiment, including the use of drugs, characterized in that mexidol is used as a drug in a dose of 0.100 to 0.800 mg / ml.
RU2012123184/14A 2012-06-05 2012-06-05 Method for controlled mexidol-induced platelet aggregation decrease in experiment RU2512788C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012123184/14A RU2512788C2 (en) 2012-06-05 2012-06-05 Method for controlled mexidol-induced platelet aggregation decrease in experiment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012123184/14A RU2512788C2 (en) 2012-06-05 2012-06-05 Method for controlled mexidol-induced platelet aggregation decrease in experiment

Publications (2)

Publication Number Publication Date
RU2012123184A true RU2012123184A (en) 2013-12-10
RU2512788C2 RU2512788C2 (en) 2014-04-10

Family

ID=49682796

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012123184/14A RU2512788C2 (en) 2012-06-05 2012-06-05 Method for controlled mexidol-induced platelet aggregation decrease in experiment

Country Status (1)

Country Link
RU (1) RU2512788C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2751964C1 (en) * 2021-02-17 2021-07-21 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Method for reducing aggregation ability of platelets

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290996B1 (en) * 1999-02-17 2001-09-18 Natreon Inc. Method of inhibiting blood platelet aggregation
RU2282855C2 (en) * 2004-04-12 2006-08-27 Иван Илларионович Тютрин Method for evaluating functional state of hemostasis system
RU2442167C1 (en) * 2010-07-21 2012-02-10 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" Method of evaluating the effectiveness of non-aggregate preparations affecting the metabolism of arachidonic acid by inhibition of cyclooxygenase-1 both individually and jointly with adp p2y12 receptor antagonist on platelet membranes of the blood to the patient receiving non-aggregate preparations
JP2012153671A (en) * 2011-01-28 2012-08-16 Ogawa & Co Ltd Platelet aggregation inhibitor

Also Published As

Publication number Publication date
RU2512788C2 (en) 2014-04-10

Similar Documents

Publication Publication Date Title
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
UY35907A (en) NEW INDAZOLCARBOXAMIDS, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES
EA201401028A1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
BR112015004499A2 (en) Pirfenidone therapy administration methods
MX365939B (en) Nuclear transport modulators and uses thereof.
PH12015501993B1 (en) Pyrazole-amide compound and medicinal uses therefor
NZ702663A (en) Nuclear transport modulators and uses thereof
EA201590161A1 (en) COMPOSITIONS OF ETHANRECEPT DIFFERENTLY DIFFERENT BY REDUCTION OF PARTICLES OF A REVERSIBLE RANGE
MX380565B (en) COENZYME Q10 COMBINATION THERAPIES FOR CANCER TREATMENT.
EA201201658A1 (en) DERIVATIVES OF PIPERIDINE AND THEIR APPLICATION FOR THE TREATMENT OF METABOLIC DISORDERS
EP4360621A3 (en) Formulations of bendamustine
UA115811C2 (en) A STABLE SOLUTION OF ASSOCIATED Baclofen, Sorbitol and Naltrexone for Oral Use
AR097619A1 (en) USE OF ACETIL-COA CARBOXYLASE INHIBITORS TO TREAT ACNÉ VULGARIS
MX344846B (en) COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ASSETS.
MX2014013101A (en) Ready to be infused gemcitabine solution.
EA201501164A1 (en) SOLID PHARMACEUTICAL MEDICINE FORM
CO6460763A2 (en) ECTOPARASITICID METHODS AND FORMULATIONS
CY1122538T1 (en) CHONDROITIN COMPLEXES FOR TRANSCUTANEOUS ABSORPTION
RU2012129115A (en) METHOD FOR TREATING ACUTE POST-PERMANENT ENDOMETRITIS IN COWS
MX368640B (en) PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION and PAIN.
RU2012123180A (en) METHOD OF CONTROLLED DECREASE OF THE AGGREGATION ACTIVITY OF THROMBOCYTES IN EXPERIMENT
EA201591644A1 (en) DOSAGE FORM CONTAINING CRYZOTINIB
EA201500368A1 (en) PHARMACEUTICAL COMPOSITION OF 1-ADAMANTYLETHYLOXY-3-MORFOLIN-2-PROPANOL OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR TREATING CARDIOVASCULAR PATHOLOGY
RU2012149676A (en) METHOD FOR TREATING CALVES WITH PATIENTS WITH SIMULIIDOTOXICOSIS

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20140606